EE315 Economic evaluation of neutralising monoclonal antibodies for the treatment of COVID-19 positive people in the community

Metry, A. orcid.org/0000-0001-7412-6093, Rafia, R. and Wailoo, A. orcid.org/0000-0002-9324-1617 (2022) EE315 Economic evaluation of neutralising monoclonal antibodies for the treatment of COVID-19 positive people in the community. In: Value in Health. ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington, DC, USA. Elsevier BV , S395-S396.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 Published by Elsevier Inc.
Dates:
  • Published (online): 25 June 2022
  • Published: July 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Funding Information:
FunderGrant number
National Institute for Health and Care Excellencen/a
Depositing User: Symplectic Sheffield
Date Deposited: 28 Jul 2022 08:42
Last Modified: 28 Jul 2022 08:42
Status: Published
Publisher: Elsevier BV
Identification Number: https://doi.org/10.1016/j.jval.2022.04.560
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)